search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
COVER STORY / ADVERTISING FEATURE


and ketone levels in children undergoing fasting before general anaesthesia, providing unprecedented insight into the prevalence and predictors of fasting- related metabolic disturbances.3 Designed as an opt-out multicentre


cohort study, FIGS enrolled children aged one month to 17 years undergoing elective procedures under general anaesthesia. The study included a broad spectrum of everyday paediatric practice, ranging from diagnostic imaging and dental procedures to general surgical interventions. Children with known endocrine or metabolic disorders, those receiving glucose-containing intravenous fluids, and patients undergoing emergency or oncology procedures were excluded to minimise confounding factors and beter characterise fasting-related metabolic changes in otherwise healthy paediatric populations.3


The primary objective of FIGS is to identify the glycaemic threshold that may trigger changes in anaesthetic management. Secondary objectives include determining clinically relevant glucose and ketone thresholds, assessing the prevalence of metabolic abnormalities, and identifying risk factors that may predispose children to hypoglycaemia or ketosis.3 The scale of FIGS reflects an exceptional national collaboration among paediatric anaesthetists, researchers, and clinical teams. Recruitment centres included major UK children’s hospitals, tertiary institutions and numerous other NHS organisations across England, Scotland, Wales, and Northern Ireland.3 In total, the study achieved recruitment of 2,902 patients, making it one of the


most comprehensive datasets ever assembled to investigate fasting- related metabolic changes in paediatric anaesthesia. Such broad participation ensures that the findings will be highly representative of contemporary paediatric perioperative practice throughout the United Kingdom.


The importance of ketones Traditionally, clinicians have focused primarily on glucose measurement when considering fasting complications. However, glucose alone may not fully reflect the metabolic impact of prolonged fasting.7,8 Ketone production is a natural adaptive


response to reduced carbohydrate availability. In young children, ketone accumulation can occur rapidly and may precede measurable hypoglycaemia. Consequently, ketone monitoring may offer additional insight into the metabolic response to fasting or physiological stress, helping to identify patients who could be considered for further evaluation before significant glucose depletion develops.9,10 This dual-marker approach is particularly relevant in paediatrics because fasting durations frequently exceed planned timelines due to surgical delays, logistical challenges, or operating theatre scheduling pressures. Understanding the relationship between glucose concentrations, ketone levels, fasting duration, and patient characteristics could enable clinicians to identify those most at risk and tailor perioperative management accordingly.


Enabling metabolic assessment A notable aspect of the FIGS study is the use of the StatStrip Xpress 2 Glucose/Ketone Meter for point-of-care measurement of blood glucose and ketones.11,12


perioperative care. First, they may help establish evidence-


based thresholds for intervention when low glucose or elevated ketone levels are identified before anaesthesia. Second, the study could improve


understanding of which children are most susceptible to metabolic complications. Factors such as age, fasting duration, procedure type, and timing of surgery may ultimately inform risk stratification strategies. Third, depending on the study findings,


the results may contribute to discussions regarding the potential role of metabolic monitoring in selected paediatric populations, particularly those undergoing prolonged fasting or procedures associated with a higher metabolic risk. The final results are expected toward the end of 2026 and are anticipated to provide important evidence regarding the prevalence and clinical significance of fasting-induced hypoglycaemia and ketosis in children.


Conclusions The FIGS study is a large multicentre investigation of the metabolic consequences of preoperative fasting in children. By combining a substantial cohort with systematic glucose and ketone measurements, the study addresses an important area of paediatric anaesthesia that has received relatively limited atention to date. While the final study results have


Conducting a large multicentre


patient cohort study requires reliable and standardised testing methods that can be used consistently across numerous healthcare institutions.13 Point-of-care technology provides


immediate results at the bedside while minimising workflow disruption within busy perioperative environments.14


The


availability of rapid glucose and ketone measurements has enabled investigators to collect real-world metabolic data on a scale that would have been challenging using conventional laboratory testing alone. Beyond its contribution to the study, this


approach reflects a broader trend toward near-patient testing and data-driven clinical decision-making, particularly in time-sensitive environments such as operating theatres and recovery units.


Potential impact on future practice The findings of FIGS have the potential to influence several aspects of paediatric


not yet been published, the FIGS study is expected to enhance understanding of fasting-related hypoglycaemia and ketosis in children. Given that the study was not designed to assess whether glucose and ketone monitoring improves clinical outcomes, its findings should be interpreted primarily in the context of characterising the metabolic effects of preoperative fasting. Depending on the results, the study


may contribute to future discussions regarding perioperative monitoring practices and the development of evidence-based guidance in paediatric anaesthesia.


For a full list of references, scan the QR code.


Dr Benjamin J Blaise MD PhD is a Consultant Paediatric Anaesthetist at Evelina London Children’s Hospital, which operates under the Guy’s and St Thomas’ NHS Foundation Trust. He is also an Honorary Senior Lecturer at King’s College London.


Further details of the FIGS study can be found at: www.bjaopen.org/article/S2772- 6096(26)00337-0/fulltext


October 2026 WWW.PATHOLOGYINPRACTICE.COM 7


PPi


© Nova Biomedical


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56